Klemen Strojan
Overview
Explore the profile of Klemen Strojan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
85
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pavlin M, Lojk J, Strojan K, Hafner-Bratkovic I, Jerala R, Leonardi A, et al.
Int J Mol Sci
. 2022 Jun;
23(11).
PMID: 35682872
Alongside physiochemical properties (PCP), it has been suggested that the protein corona of nanoparticles (NPs) plays a crucial role in the response of immune cells to NPs. However, due to...
2.
Skocaj M, Bizjak M, Strojan K, Lojk J, Kreft M, Mis K, et al.
Int J Mol Sci
. 2020 Oct;
21(20).
PMID: 33066271
Many studies evaluated the short-term in vitro toxicity of nanoparticles (NPs); however, long-term effects are still not adequately understood. Here, we investigated the potential toxic effects of biomedical (polyacrylic acid...
3.
Strojan K, Lojk J, Bregar V, Erdani-Kreft M, Svete J, Veranic P, et al.
Acta Chim Slov
. 2017 Sep;
64(3):543-548.
PMID: 28862305
Normal porcine urothelial cells have been shown to have a much lower rate of endocytosis than urothelial papillary neoplasm cells. This could be used as a mechanism for selective delivery...
4.
Lojk J, Bregar V, Strojan K, Hudoklin S, Veranic P, Pavlin M, et al.
Histochem Cell Biol
. 2017 Aug;
149(1):45-59.
PMID: 28821965
The blood-urine barrier is the tightest and most impermeable barrier in the body and as such represents a problem for intravesical drug delivery applications. Differentiation-dependent low endocytotic rate of urothelial...
5.
Lojk J, Strojan K, Mis K, Bregar B, Bratkovic I, Bizjak M, et al.
Toxicol Lett
. 2017 Feb;
270:108-118.
PMID: 28223195
Potential nanoparticle (NP) toxicity is one of crucial problems that limit the applicability of NPs. When designing NPs for biomedical and biotechnological applications it is thus important to understand the...
6.
Strojan K, Lojk J, Bregar V, Veranic P, Pavlin M
Toxicol In Vitro
. 2017 Feb;
41:12-20.
PMID: 28216176
Polyethyleneimine (PEI) is a polycationic compound frequently used as a transfection agent. However, cytotoxicity of PEI and PEI-coated nanoparticles (PEI NPs) is still a major obstacle in its use. In...
7.
Strojan K, Leonardi A, Bregar V, Krizaj I, Svete J, Pavlin M
PLoS One
. 2017 Jan;
12(1):e0169552.
PMID: 28052135
Protein corona of nanoparticles (NPs), which forms when these particles come in to contact with protein-containing fluids, is considered as an overlooked factor in nanomedicine. Through numerous studies it has...